Mary E Hamby
6PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 03, 2026
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease.Everard G B Vijverberg, Douglas W Scharre, Michael Woodward
|Jun 23, 2025
Identification of cerebrospinal fluid pharmacodynamic biomarkers and molecular correlates of brain activity in a Phase 2 clinical trial of the Alzheimer's disease drug candidate CT1812.Valentina Di Caro, Eunah Cho, Hilary A North
|Aug 21, 2024
CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease.Britney N Lizama, Claire Williams, Hilary A North
|May 12, 2023
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.Kelsie M LaBarbera, Yvette I Sheline, Nicholas J Izzo
|Apr 13, 2023
Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases.Britney N Lizama, Jennifer Kahle, Susan M Catalano
|Jul 15, 2020
Dual Leucine Zipper Kinase Is Constitutively Active in the Adult Mouse Brain and Has Both Stress-Induced and Homeostatic Functions.Sunil Goodwani, Celia Fernandez, Paul J Acton
Pageof 1
